Best VCs for Life Sciences

246 venture capitalists actively investing in Life Sciences.

246
Active VCs
0
Funds
0
Deals
#1Nimi Katragadda

Partner

BoxGroup

Nimi is a generalist early-stage Partner with a long-running, publicly documented focus on healthcare and life sciences, fintech, marketplaces, and software. Her current activity extends that lens int

BoxGroup currently publishes a firm-wide maximum investment of $1M. Historical sources reported smaller firm checks and third-party profiles estimate $250K–$750K for Nimi, but no primary source confirms a current personal range.
Pre-SeedSeedSeries A
#2Brandon Reeves

Partner

Lux Capital

Brandon backs technical platforms and applications across software, AI, defense, and manufacturing. A recurring theme is open or developer-led infrastructure that turns frontier capability into produc

No verified personal or standard Lux check-size range is published. Brandon invests at both early and growth stages; disclosed financing rounds, such as Hugging Face's $15M Series A, are total rounds and not his personal allocation range.
SeedSeries AEarly Stage
#3Linda Olson

Office Manager

Clarevia

Linda Olson is listed in a Office Manager capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#4Jessica Owens

Co-Founder and General Partner

INITIATE Ventures

Jessica Owens invests or supports investments through INITIATE Ventures's published strategy: Build and back AI-native healthcare and life-sciences companies, combining investing with hands-on company

$500K-$3M checks were disclosed at launch; no person-specific range is public.
InceptionPre-SeedSeed
#5Cheryl R. Blanchard, PhD

Executive in Residence

Clarevia

Cheryl R. Blanchard, PhD invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from ther

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#6Shelly Lanning

Venture Partner

Clarevia

Shelly Lanning invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic an

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#7Becky Hoerman

Controller

Clarevia

Becky Hoerman is listed in a Controller capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#8Iana Dimkova

Co-Founder and General Partner

INITIATE Ventures

Iana Dimkova invests or supports investments through INITIATE Ventures's published strategy: Build and back AI-native healthcare and life-sciences companies, combining investing with hands-on company

$500K-$3M checks were disclosed at launch; no person-specific range is public.
InceptionPre-SeedSeed
#9Melinda Gloriosa

Vice President, Investments

R1 Capital

Melinda Gloriosa invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from p

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#10Justin Probst

Vice President, Finance and Operations

R1 Capital

Justin Probst is listed in a Vice President, Finance and Operations capacity at R1 Capital. The firm does not publish a person-specific investment thesis for this role; the profile therefore preserves

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#11Meghan Hoffman

Associate, Life Sciences Investments

R1 Capital

Meghan Hoffman invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from pro

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#12Riley Shelton

Associate, Investments

R1 Capital

Riley Shelton invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proo

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#13Grant Berliner

Associate, Investments

R1 Capital

Grant Berliner invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from pro

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#14Parker MacDonell

Venture Partner

R1 Capital

Parker MacDonell invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from p

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#15Wayne Embree

Venture Partner

R1 Capital

Wayne Embree invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#16Kim Garland

Venture Partner

R1 Capital

Kim Garland invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#17Srini Koushik

Venture Partner, AI

R1 Capital

Srini Koushik invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proo

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#18Howard Cox

Special Limited Partner

Greylock Partners

Howard's record reflects a long-horizon institution-builder and governance lens developed across Greylock, the NVCA, In-Q-Tel, Stryker, investment committees and public-interest institutions. It is us

No current personal or Greylock check range is attributable to Howard, and his emeritus Special Limited Partner status should not be treated as current check-writing authority. Contact Greylock's active investors for stage, allocation, ownership and process.
Historical Venture InvestingBoard GovernanceInstitutional Investment Oversight
#19Shahram Seyedin-Noor

Founder + Managing Partner

Civilization Ventures

Shahram Seyedin-Noor invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeu

Civilization Ventures does not publish a standard check-size range on its official site.
Pre-SeedSeed
#20Sonia Setayesh

Investment Partner

Civilization Ventures

Sonia Setayesh invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics a

Civilization Ventures does not publish a standard check-size range on its official site.
Pre-SeedSeed
#21Manuel Lopez-Figueroa

Operating Partner

Civilization Ventures

Manuel Lopez-Figueroa invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therape

Civilization Ventures does not publish a standard check-size range on its official site.
Pre-SeedSeed
#22Sarah Loveland

Senior Associate

Civilization Ventures

Sarah Loveland invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics a

Civilization Ventures does not publish a standard check-size range on its official site.
Pre-SeedSeed
#23Angelica Parente

Operating Partner

Civilization Ventures

Angelica Parente invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics

Civilization Ventures does not publish a standard check-size range on its official site.
Pre-SeedSeed
#24Omar Yamout

Associate

Civilization Ventures

Omar Yamout invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and

Civilization Ventures does not publish a standard check-size range on its official site.
Pre-SeedSeed
#25Carli Kaleta

Associate Intern

Civilization Ventures

Carli Kaleta invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and

Civilization Ventures does not publish a standard check-size range on its official site.
Pre-SeedSeed
#26Matt Wheeler

CFO

Civilization Ventures

Matt Wheeler is listed in a CFO capacity at Civilization Ventures. The official roster does not establish a personal investment mandate for this role; the firm's strategy is included only as organizat

Civilization Ventures does not publish a standard check-size range on its official site.
Pre-SeedSeed
#27Mark Gorenberg

Founder & Managing Director

Zetta Venture Partners

Mark Gorenberg invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and techn

Zetta Venture Partners does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#28Apoorva Pandhi

Managing Director

Zetta Venture Partners

Apoorva Pandhi invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and techn

Zetta Venture Partners does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#29Jocelyn Goldfein

Managing Director

Zetta Venture Partners

Jocelyn Goldfein invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and tec

Zetta Venture Partners does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#30Dylan Reid

Managing Director

Zetta Venture Partners

Dylan Reid invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technical

Zetta Venture Partners does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#31Annelies Gamble

Partner

Zetta Venture Partners

Annelies Gamble invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and tech

Zetta Venture Partners does not publish a standard current check-size range on its official site.
Pre-SeedSeedEarly Stage
#32Scott Addonizio

General Partner

Cultivation Capital

Scott Addonizio is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#33Verlensia Bates

Accounting and Operations Coordinator

Cultivation Capital

Verlensia Bates is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#34Will Cadell

Venture Advisor

Cultivation Capital

Will Cadell is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thro

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#35Andy Dearing

General Partner

Cultivation Capital

Andy Dearing is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thr

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#36Joel Crater

General Partner

Cultivation Capital

Joel Crater is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thro

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#37Caleb Eidem

General Counsel

Cultivation Capital

Caleb Eidem is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thro

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#38Scott Herman

Venture Advisor

Cultivation Capital

Scott Herman is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thr

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#39Elise Miller Hoffman

General Partner

Cultivation Capital

Elise Miller Hoffman is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#40Cliff Holekamp

Co-Founder & General Partner

Cultivation Capital

Cliff Holekamp is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-t

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#41Kristina Hood

Principal

Cultivation Capital

Kristina Hood is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-th

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#42Kyle Kerns

CFO and Operations Lead

Cultivation Capital

Kyle Kerns is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-throu

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#43Catherine Matthes

Venture Advisor

Cultivation Capital

Catherine Matthes is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising see

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#44Brian Matthews

Co-Founder & General Partner

Cultivation Capital

Brian Matthews is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-t

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#45Paul Meier

Partner

Cultivation Capital

Paul Meier is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-throu

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#46Sean Morris

General Partner

Cultivation Capital

Sean Morris is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thro

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#47Dennis Muilenburg

Venture Advisor

Cultivation Capital

Dennis Muilenburg is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising see

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#48David Narrow

Venture Advisor

Cultivation Capital

David Narrow is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thr

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#49Matt Phimphavong

Principal

Cultivation Capital

Matt Phimphavong is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#50Grant Pothast

General Partner

Cultivation Capital

Grant Pothast is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-th

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#51Rick Ryan

General Partner

Cultivation Capital

Rick Ryan is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-throug

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#52Bobby Sandage

General Partner

Cultivation Capital

Bobby Sandage is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-th

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#53Martha Schlicher

General Partner

Cultivation Capital

Martha Schlicher is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#54Barry Sandweiss

General Partner

Cultivation Capital

Barry Sandweiss is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#55Bill Schmidt

General Partner

Cultivation Capital

Bill Schmidt is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thr

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#56David Smoller

General Partner

Cultivation Capital

David Smoller is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-th

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#57Timothy Stern

General Partner

Cultivation Capital

Timothy Stern is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-th

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#58John True

General Partner

Cultivation Capital

John True is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-throug

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#59Paul Weber

General Partner

Cultivation Capital

Paul Weber is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-throu

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#60Kyle Welborn

Co-Founder & General Partner

Cultivation Capital

Kyle Welborn is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thr

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#61Heather Wood

General Partner

Cultivation Capital

Heather Wood is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-thr

$100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
SeedSeries ASeries B
#62Ben Patz

Managing Partner

DeepWork Capital

Ben Patz is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology a

The firm does not publish a person-specific check-size range on its current official website.
SeedSeries A
#63Kathy Chiu

Managing Partner

DeepWork Capital

Kathy Chiu is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology

The firm does not publish a person-specific check-size range on its current official website.
SeedSeries A
#64Mitchel Laskey

Managing Partner

DeepWork Capital

Mitchel Laskey is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A techno

The firm does not publish a person-specific check-size range on its current official website.
SeedSeries A
#65Ken Hall

Vice President

DeepWork Capital

Ken Hall is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology a

The firm does not publish a person-specific check-size range on its current official website.
SeedSeries A
#66Jackson Streeter, MD

Venture Partner

DeepWork Capital

Jackson Streeter, MD is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A

The firm does not publish a person-specific check-size range on its current official website.
SeedSeries A
#67Kristopher Lancaster

Associate

DeepWork Capital

Kristopher Lancaster is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A

The firm does not publish a person-specific check-size range on its current official website.
SeedSeries A
#68Stacey Barnes

Senior Business Operations Manager

CincyTech

Stacey Barnes is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, research

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#69Henry Haverty

Accounting Intern

CincyTech

Henry Haverty is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, research

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#70Logan Hille, Ph.D.

Life Sciences Analyst

CincyTech

Logan Hille, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, res

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#71Kerry Hull, CPA, MBA

Chief Financial Officer & Chief Operating Officer

CincyTech

Kerry Hull, CPA, MBA is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, r

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#72Sean Kwiat

Vice President, Investments

CincyTech

Sean Kwiat is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#73Liam McAllister

Investment Analyst

CincyTech

Liam McAllister is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, resear

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#74Bryan McCleary

Executive in Residence

CincyTech

Bryan McCleary is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researc

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#75Kenneth Morand, Ph.D.

Life Sciences Partner

CincyTech

Kenneth Morand, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders,

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#76Emma Off

CEO, President, & Partner

CincyTech

Emma Off is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers,

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#77Maureen Stancik Boyce, PhD

Managing Partner

Good Growth Capital

Maureen Stancik Boyce, PhD is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early pot

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#78Amy Salzhauer

Managing Partner

Good Growth Capital

Amy Salzhauer is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in lif

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#79Carolyne LaSala

Managing Partner

Good Growth Capital

Carolyne LaSala is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in l

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#80David Mendez

Managing Partner

Good Growth Capital

David Mendez is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#81Sophie Hagerty

Principal

Good Growth Capital

Sophie Hagerty is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in li

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#82Aditi Rajagopal

Principal

Good Growth Capital

Aditi Rajagopal is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in l

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#83Ziad Sarby

Associate

Good Growth Capital

Ziad Sarby is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life s

The firm does not publish a person-specific check-size range on its current official website.
Pre-SeedSeedSeries A
#84Marc Averitt

Co-Founder, Managing Director

Okapi Venture Capital

Marc Averitt invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Souther

Okapi Venture Capital does not publish a standard check-size range on its official site.
SeedEarly Stage
#85Jeff Bocan

Managing Director

Okapi Venture Capital

Jeff Bocan invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern

Okapi Venture Capital does not publish a standard check-size range on its official site.
SeedEarly Stage
#86John Waller

Managing Director, Venture Partner

Okapi Venture Capital

John Waller invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern

Okapi Venture Capital does not publish a standard check-size range on its official site.
SeedEarly Stage
#87Sharon Stevenson

Co-Founder, Managing Director, Venture Partner

Okapi Venture Capital

Sharon Stevenson invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Sou

Okapi Venture Capital does not publish a standard check-size range on its official site.
SeedEarly Stage
#88Hayes Barnes

Director of Marketing

Elevate Ventures

Hayes Barnes is listed in a Director of Marketing capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#89Marli Carmack

Office Manager

Elevate Ventures

Marli Carmack is listed in a Office Manager capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and u

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#90Andie Hines-Lagemann

Director of Engagement and EQ Practitioner

Elevate Ventures

Andie Hines-Lagemann invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs,

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#91Chris Huxhold

Chief Financial Officer

Elevate Ventures

Chris Huxhold is listed in a Chief Financial Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinct

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#92Brighid King

Platform Operations Manager

Elevate Ventures

Brighid King is listed in a Platform Operations Manager capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role disti

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#93Nicholas Kuhn

Vice President of Hardtech

Elevate Ventures

Nicholas Kuhn invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentors

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#94Phil Lodato

General Counsel and Chief Compliance Officer

Elevate Ventures

Phil Lodato is listed in a General Counsel and Chief Compliance Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#95Makenzie Norris

Vice President of Life Sciences

Elevate Ventures

Makenzie Norris invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mento

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#96Jacob Schpok

Partner and Head of Platform

Elevate Ventures

Jacob Schpok is listed in a Partner and Head of Platform capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role dist

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#97Erica Schweyer

Chief of Staff

Elevate Ventures

Erica Schweyer is listed in a Chief of Staff capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#98Muhammad Yasin

Chief Marketing Officer

Elevate Ventures

Muhammad Yasin is listed in a Chief Marketing Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinc

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#99Landon Young

Vice President of Pre-Seed

Elevate Ventures

Landon Young invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorsh

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#100Paul D'Amato

Chief Executive Officer and Founding Partner

Michigan Capital Network

Paul D'Amato invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, w

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#101Jody Vanderwel

Founding Partner

Michigan Capital Network

Jody Vanderwel invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies,

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#102Dale Grogan

Managing Partner

Michigan Capital Network

Dale Grogan invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, wi

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#103Meagan Malm

Partner and Director of Operations

Michigan Capital Network

Meagan Malm is listed in a Partner and Director of Operations capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves t

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#104Lynn Bishop

Operating Partner

Michigan Capital Network

Lynn Bishop invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, wi

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#105Emily Sarata

Director of Engagement

Michigan Capital Network

Emily Sarata invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, w

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#106Kalina Foster

Platform Manager

Michigan Capital Network

Kalina Foster is listed in a Platform Manager capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinc

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#107Roshan Atluri

Senior Software Engineer and IT Manager

Michigan Capital Network

Roshan Atluri is listed in a Senior Software Engineer and IT Manager capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile pres

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#108Simran Kalra

Investment Analyst

Michigan Capital Network

Simran Kalra invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, w

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#109Savannah Tuttle

Executive Assistant and Operations Manager

Michigan Capital Network

Savannah Tuttle is listed in a Executive Assistant and Operations Manager capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#110Khushi Gupta

Investment Analyst Intern

Michigan Capital Network

Khushi Gupta invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, w

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#111Nader Motamedy

Managing Partner & Investment Committee Member

Safar Partners

Nader Motamedy invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and l

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#112Jeff Wesley

Executive Director

Michigan Rise

Jeff Wesley invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful o

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#113Pete Martin

Director, Portfolio Management

Michigan Rise

Pete Martin invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful o

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#114Matt Okoneski

Director, Venture Investments

Michigan Rise

Matt Okoneski invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#115Tommy Skinner

Director, Venture Investments

Michigan Rise

Tommy Skinner invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#116Karis D'Alessandro

Venture Associate

Michigan Rise

Karis D'Alessandro invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meani

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#117Moody Mattan

Venture Associate

Michigan Rise

Moody Mattan invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#118Vikram Mohan

Venture Associate

Michigan Rise

Vikram Mohan invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaningful

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#119Calvin VanderWal

Venture Associate

Michigan Rise

Calvin VanderWal invests or supports investments through Michigan Rise's published strategy: Provide strategic early-stage funding and ecosystem support to high-growth technology startups with meaning

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#120Arunas Chesonis

Managing Partner & Investment Committee Member

Safar Partners

Arunas Chesonis invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#121Nichole Maguire

Venture Coordinator

Michigan Rise

Nichole Maguire is listed in a Venture Coordinator capacity at Michigan Rise. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction a

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#122Sahba Vaziri

Partner, CFO, Investment Committee Member

Safar Partners

Sahba Vaziri is listed in a Partner, CFO, Investment Committee Member capacity at Safar Partners. The official roster does not establish a personal investment mandate for this role; the firm's strateg

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#123Piyush Bharti

Operating Partner

Safar Partners

Piyush Bharti invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and li

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#124Tim Bowe

COO and Head of Operating Partners

Safar Partners

Tim Bowe invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life sc

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#125Rob Fleischman

Operating Partner

Safar Partners

Rob Fleischman invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and l

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#126Roberta Sydney

Operating Partner

Safar Partners

Roberta Sydney invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and l

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#127Vera Schroeder

Partner & Investment Committee Member

Safar Partners

Vera Schroeder invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and l

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#128Parinaz Motamedy

Partner & Investment Committee Member

Safar Partners

Parinaz Motamedy invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#129Arda Kotikian

Associate

Safar Partners

Arda Kotikian invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and li

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#130Leslie Hartford

Manager of Administration

Safar Partners

Leslie Hartford is listed in a Manager of Administration capacity at Safar Partners. The official roster does not establish a personal investment mandate for this role; the firm's strategy is included

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#131Tony Cheung

Manager of Systems & Operations

Safar Partners

Tony Cheung is listed in a Manager of Systems & Operations capacity at Safar Partners. The official roster does not establish a personal investment mandate for this role; the firm's strategy is includ

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#132Hannah Jacobs

Associate

Safar Partners

Hannah Jacobs invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and li

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#133Andy Cohen

Associate Partner

Safar Partners

Andy Cohen invests or supports investments through Safar Partners's published strategy: Invest in university-originated technologies across cleantech and advanced materials, AI and robotics, and life

Safar Partners does not publish a standard check-size range on its official site.
InceptionSeedEarly Stage
#134Toph Day

Chief Executive Officer

Elevate Ventures

Toph Day invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship,

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#135Myles Grote

Partner

Elevate Ventures

Myles Grote invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorshi

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#136Drew Hannel

Analyst

Elevate Ventures

Drew Hannel invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorshi

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#137Jay Harmas

Director of Portfolio Success

Elevate Ventures

Jay Harmas invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#138Asa Kelly

Vice President of Investment Operations and Portfolio Analytics

Elevate Ventures

Asa Kelly is listed in a Vice President of Investment Operations and Portfolio Analytics capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#139Cy Megnin

Vice President of Software

Elevate Ventures

Cy Megnin invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship,

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#140Patrick Sweeney

Principal

Elevate Ventures

Patrick Sweeney invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mento

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#141Matt Tyner

Managing Partner

Elevate Ventures

Matt Tyner invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#142Ben Weber

Senior Accountant

Elevate Ventures

Ben Weber is listed in a Senior Accountant capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and us

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#143Logan White

Analyst

Elevate Ventures

Logan White invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorshi

$20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Pre-SeedSeedEarly Stage
#144Ryan Ellis

Chief Financial Officer

Michigan Capital Network

Ryan Ellis is listed in a Chief Financial Officer capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role dis

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#145Jenni Li

Senior Principal

Michigan Capital Network

Jenni Li invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#146Abid Ali

Principal

Michigan Capital Network

Abid Ali invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#147Jake Standerfer

Controller

Michigan Capital Network

Jake Standerfer is listed in a Controller capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#148Abiola Olatoye

Associate

Michigan Capital Network

Abiola Olatoye invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies,

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#149Greeshma Muddam

Accountant

Michigan Capital Network

Greeshma Muddam is listed in a Accountant capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction

Michigan Capital Network does not publish a standard current check-size range on its official site.
SeedEarly Stage
#150Abdel Diab

Data Analyst

Michigan Rise

Abdel Diab is listed in a Data Analyst capacity at Michigan Rise. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the

Michigan Rise does not publish a single standard current check range on its homepage; official program materials describe staged early investments up to $250K.
Pre-SeedSeedEarly Stage
#151Eric Rosenfeld

Fund Development

Oregon Venture Fund

At the firm level, Oregon Venture Fund backs ambitious startups and growth companies with an Oregon or Southern Washington connection and uses its investor network to support diligence and company bui

$500K-$5M
Pre-seed through Series A
#152Lynn Fletcher

Operations

Oregon Venture Fund

At the firm level, Oregon Venture Fund backs ambitious startups and growth companies with an Oregon or Southern Washington connection and uses its investor network to support diligence and company bui

$500K-$5M
Pre-seed through Series A
#153Alline Akintore

Research & Diligence

Oregon Venture Fund

At the firm level, Oregon Venture Fund backs ambitious startups and growth companies with an Oregon or Southern Washington connection and uses its investor network to support diligence and company bui

$500K-$5M
Pre-seed through Series A
#154Deepthi Madhava

Diligence & Investment Sourcing

Oregon Venture Fund

At the firm level, Oregon Venture Fund backs ambitious startups and growth companies with an Oregon or Southern Washington connection and uses its investor network to support diligence and company bui

$500K-$5M
Pre-seed through Series A
#155Melissa Freeman

Capital Raising & Investor Relations

Oregon Venture Fund

At the firm level, Oregon Venture Fund backs ambitious startups and growth companies with an Oregon or Southern Washington connection and uses its investor network to support diligence and company bui

$500K-$5M
Pre-seed through Series A
#156Mary Geyer

Fund Accounting & Data

Oregon Venture Fund

At the firm level, Oregon Venture Fund backs ambitious startups and growth companies with an Oregon or Southern Washington connection and uses its investor network to support diligence and company bui

$500K-$5M
Pre-seed through Series A
#157Matt Compton

Portfolio Success

Oregon Venture Fund

At the firm level, Oregon Venture Fund backs ambitious startups and growth companies with an Oregon or Southern Washington connection and uses its investor network to support diligence and company bui

$500K-$5M
Pre-seed through Series A
#158Nitin Rai

Founder & Managing Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#159Kumar Sripadam

General Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#160Ben Nahir, PhD

Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#161Vageesh Jha

Associate (Fund Operations & Administration)

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#162Brandon Ross

Senior Associate-Analyst

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#163Allie Persitz

Operating Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#164Anu Shukla

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#165Dipty Desai

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#166Giovanni Magni

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#167Soumitra Sengupta

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#168Annu Navani, MD

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#169Krishna Chittabathini

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#170Srivatsan Laxman

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#171Supriya Rao

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#172Tariq Q. Khan

Venture Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#173Donn Dimond

Limited Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#174Doug Fieldhouse

Limited Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#175Lateef Jackson

Limited Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#176Jill Nelson

Executive Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#177Michael Choi

Executive Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#178Chris Bright

Executive Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#179Randy Lund

Executive Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#180Ana Chaud

Executive Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#181Ketan Sampat

Executive Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#182Robin Jones

Executive Partner

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#183Raghu Raghavan

Partner Emeritus

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#184Pam Gates

Controller

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#185Barbara Johnson

Executive Assistant

Elevate Capital

At the firm level, Elevate Capital invests in overlooked entrepreneurs, including women and minority founders, while also funding high-risk research-driven innovation through its gap and SSBCI strateg

$25K-$2M
Pre-seed through Series A
#186Charlie Hipwood

President & CEO

MassVentures

Charlie Hipwood contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's in

MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.
Pre-SeedSeedEarly Stage
#187Vinit Nijhawan

Managing Director

MassVentures

Vinit Nijhawan contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's inn

MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.
Pre-SeedSeedEarly Stage
#188Priya Yadav

Vice President Investments

MassVentures

Priya Yadav contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innova

MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.
Pre-SeedSeedEarly Stage
#189Stacy Swider

Vice President Investments

MassVentures

Stacy Swider contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innov

MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.
Pre-SeedSeedEarly Stage
#190Myron Kassaraba

Vice President Investments

MassVentures

Myron Kassaraba contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's in

MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.
Pre-SeedSeedEarly Stage
#191Sienna Leis

Venture Development Manager

MassVentures

Sienna Leis contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innova

MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.
Pre-SeedSeedEarly Stage
#192Whitney Leslie

Vice President Portfolio Analytics & IR

MassVentures

Whitney Leslie contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's inn

MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.
Pre-SeedSeedEarly Stage
#193Matt Snow

Manager Investments

MassVentures

Matt Snow contributes to MassVentures's published strategy: Fund research-driven Massachusetts startups with venture investment, grants and commercialization support to strengthen the state's innovati

MassVentures does not publish one standard check-size range across its equity and grant programs on its current website.
Pre-SeedSeedEarly Stage
#194David Michael

Managing Partner

Anzu Partners

David Michael contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#195David Seldin

Managing Partner

Anzu Partners

David Seldin contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#196Whitney Haring-Smith

Managing Partner

Anzu Partners

Whitney Haring-Smith contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#197Debrah Herman, CPA

Partner

Anzu Partners

Debrah Herman, CPA contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization su

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#198Jimmy Kan, PhD

Partner

Anzu Partners

Jimmy Kan, PhD contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppor

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#199William H. Strong

Partner

Anzu Partners

William H. Strong contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization sup

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#200Michael Burychka

Partner

Anzu Partners

Michael Burychka contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization supp

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#201Jason Smith, PhD

Partner

Anzu Partners

Jason Smith, PhD contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization supp

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#202Jenna Abelli

Principal, Investment

Anzu Partners

Jenna Abelli contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#203Henk Both, PhD

Principal, Investment

Anzu Partners

Henk Both, PhD contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppor

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#204Josh Stiling

Principal, Investment

Anzu Partners

Josh Stiling contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#205Brandon Fleischman

General Counsel

Anzu Partners

Brandon Fleischman contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization su

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#206Daniel Hirsch

Principal, Legal

Anzu Partners

Daniel Hirsch contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#207Steven Battista

Principal, Operational Excellence

Anzu Partners

Steven Battista contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppo

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#208Jennifer Ting

Principal, Fund Accounting

Anzu Partners

Jennifer Ting contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#209Rebecca Chimwanda

Principal, People Operations

Anzu Partners

Rebecca Chimwanda contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization sup

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#210Beverly Himes, CPA

Principal, SVP, Financial & Government Accounting

Anzu Partners

Beverly Himes, CPA contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization su

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#211John Sears, PhD

Principal, Intellectual Property

Anzu Partners

John Sears, PhD contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppo

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#212Wendy Papakostandini

Principal, Talent

Anzu Partners

Wendy Papakostandini contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#213Kalyn Schieffer

Principal, Public Relations

Anzu Partners

Kalyn Schieffer contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppo

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#214Jordan Borawski

Senior People Operations Partner

Anzu Partners

Jordan Borawski contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppo

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#215Jacquelyn Brown

Accounting Manager

Anzu Partners

Jacquelyn Brown contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppo

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#216Jerry Carlisle Jr.

Vice President, Finance and Accounting

Anzu Partners

Jerry Carlisle Jr. contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization su

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#217Madi Casey

Technical Recruiter

Anzu Partners

Madi Casey contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#218Symone Collins

Payroll Specialist

Anzu Partners

Symone Collins contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppor

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#219Victoria DiGiustino

Senior Accountant

Anzu Partners

Victoria DiGiustino contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization s

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#220Neika Fatehi

Senior Digital Marketing Manager

Anzu Partners

Neika Fatehi contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#221Angela Feller

Senior Executive Assistant

Anzu Partners

Angela Feller contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#222Claudia Gau

Senior Accountant

Anzu Partners

Claudia Gau contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#223Latoya Green

Accounting Manager

Anzu Partners

Latoya Green contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#224Patrick Irvan

Assistant Fund Controller

Anzu Partners

Patrick Irvan contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#225Melissa Johnson

Senior Accountant

Anzu Partners

Melissa Johnson contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppo

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#226Kaitlyn Lagasca

Manager, Talent Acquisition

Anzu Partners

Kaitlyn Lagasca contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppo

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#227Kyle Manning

Director of Accounting

Anzu Partners

Kyle Manning contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#228Katie Messner

Director of Operations

Anzu Partners

Katie Messner contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#229Rebecca Parcher

Director of Accounting

Anzu Partners

Rebecca Parcher contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppo

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#230Wilson Poole

Investment Director

Anzu Partners

Wilson Poole contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#231Emma Ramrattan

Senior Accountant

Anzu Partners

Emma Ramrattan contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization suppor

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#232Lex Smith

Accountant

Anzu Partners

Lex Smith contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#233Lori Swann

Senior Accountant

Anzu Partners

Lori Swann contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#234Ittie Rehani

Director, Capital Solutions & Investor Relations

Anzu Partners

Ittie Rehani contributes to Anzu Partners's published strategy: Invest in breakthrough industrial and life-science technologies while supplying deep operating, technical and commercialization support.

Anzu Partners does not publish a standard check-size range on its current official website.
Early StageGrowth StagePrivate Credit
#235Jim Adox

Managing Partner

Clarevia

Jim Adox invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and devi

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#236Scott Button

Partner

Clarevia

Scott Button invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#237Paul Weiss

Partner

Clarevia

Paul Weiss invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and de

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#238David Arnstein

Partner and Chief Financial Officer

Clarevia

David Arnstein is listed in a Partner and Chief Financial Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared c

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#239John Neis

Partner

Clarevia

John Neis invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and dev

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#240Joe Amaral, MD

Chief Medical and Scientific Officer

Clarevia

Joe Amaral, MD is listed in a Chief Medical and Scientific Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#241Jenni Le

Principal

Clarevia

Jenni Le invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and devi

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#242Margaret Kaczor Andrew

Venture Partner

Clarevia

Margaret Kaczor Andrew invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therap

Clarevia does not publish a standard current check-size range on its official site.
SeedEarly StageGrowth
#243Tom Walker

Founder and Managing Partner

R1 Capital

Tom Walker invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof o

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#244Ryan Helon

Chief Investment Officer and Managing Partner

R1 Capital

Ryan Helon invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof o

R1 Capital does not publish a standard person-specific check-size range on its current website.
Proof of ConceptPre-SeedSeed
#245David Yang

Partner

Lux Capital

David backs scientific founders in therapeutics, R&D tooling, and biopharma infrastructure, looking for research edges early enough to matter. His research and company-building background supports a t

Firm-level: Lux says it can invest from an initial $100K through high-conviction follow-ons as large as $100M across the company-building arc. This is not David's personal standard check range.
InceptionPre-SeedSeed
#246Melina Mai

Principal

Big Pi Ventures

Melina invests in early-stage AI, robotics, B2B SaaS, life sciences, and climate technology. Her engineering and deep-learning background supports technical diligence, while her strategy-and-operation

€500K-€3M initial investments for Melina's early-stage work; Big Pi's wider family-of-funds range extends to €30M.
SeedEarly Stage